BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38140710)

  • 1. Correction to: NeoFox: annotating neoantigen candidates with neoantigen features.
    Bioinformatics; 2023 Dec; 39(12):. PubMed ID: 38140710
    [No Abstract]   [Full Text] [Related]  

  • 2. NeoFox: annotating neoantigen candidates with neoantigen features.
    Lang F; Riesgo-Ferreiro P; Löwer M; Sahin U; Schrörs B
    Bioinformatics; 2021 Nov; 37(22):4246-4247. PubMed ID: 33970219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple instance learning to predict immune checkpoint blockade efficacy using neoantigen candidates.
    Lang F; Sorn P; Schrörs B; Weber D; Kramer S; Sahin U; Löwer M
    iScience; 2023 Nov; 26(11):108014. PubMed ID: 37965155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement in neoantigen prediction via integration of RNA sequencing data for variant calling.
    Nguyen BQT; Tran TPD; Nguyen HT; Nguyen TN; Pham TMQ; Nguyen HTP; Tran DH; Nguyen V; Tran TS; Pham TN; Le MT; Phan MD; Giang H; Nguyen HN; Tran LS
    Front Immunol; 2023; 14():1251603. PubMed ID: 37731488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of an aggressive orthotopic murine glioblastoma model with combination checkpoint blockade and a multivalent neoantigen vaccine.
    Liu CJ; Schaettler M; Blaha DT; Bowman-Kirigin JA; Kobayashi DK; Livingstone AJ; Bender D; Miller CA; Kranz DM; Johanns TM; Dunn GP
    Neuro Oncol; 2020 Sep; 22(9):1276-1288. PubMed ID: 32133512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer.
    Liu S; Matsuzaki J; Wei L; Tsuji T; Battaglia S; Hu Q; Cortes E; Wong L; Yan L; Long M; Miliotto A; Bateman NW; Lele SB; Chodon T; Koya RC; Yao S; Zhu Q; Conrads TP; Wang J; Maxwell GL; Lugade AA; Odunsi K
    J Immunother Cancer; 2019 Jun; 7(1):156. PubMed ID: 31221207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteogenomic identification of an immunogenic HLA class I neoantigen in mismatch repair-deficient colorectal cancer tissue.
    Hirama T; Tokita S; Nakatsugawa M; Murata K; Nannya Y; Matsuo K; Inoko H; Hirohashi Y; Hashimoto S; Ogawa S; Takemasa I; Sato N; Hata F; Kanaseki T; Torigoe T
    JCI Insight; 2021 Jul; 6(14):. PubMed ID: 34185709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GNIFdb: a neoantigen intrinsic feature database for glioma.
    Li W; Sun T; Li M; He Y; Li L; Wang L; Wang H; Li J; Wen H; Liu Y; Chen Y; Fan Y; Xin B; Zhang J
    Database (Oxford); 2022 Feb; 2022():. PubMed ID: 35150127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. neoDL: a novel neoantigen intrinsic feature-based deep learning model identifies IDH wild-type glioblastomas with the longest survival.
    Sun T; He Y; Li W; Liu G; Li L; Wang L; Xiao Z; Han X; Wen H; Liu Y; Chen Y; Wang H; Li J; Fan Y; Zhang W; Zhang J
    BMC Bioinformatics; 2021 Jul; 22(1):382. PubMed ID: 34301201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of Neoantigen-Specific Cytotoxic T Cells and Construction of T-cell Receptor-Engineered T Cells for Ovarian Cancer.
    Matsuda T; Leisegang M; Park JH; Ren L; Kato T; Ikeda Y; Harada M; Kiyotani K; Lengyel E; Fleming GF; Nakamura Y
    Clin Cancer Res; 2018 Nov; 24(21):5357-5367. PubMed ID: 29720506
    [No Abstract]   [Full Text] [Related]  

  • 11. Neoantigen-reactive T cells exhibit effective anti-tumor activity against colorectal cancer.
    Yu Y; Zhang J; Ni L; Zhu Y; Yu H; Teng Y; Lin L; Xue Z; Xue X; Shen X; Song H; Su X; Sun W; Cai Z
    Hum Vaccin Immunother; 2022 Dec; 18(1):1-11. PubMed ID: 33689574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of shared neoantigens in esophageal carcinoma by the combination of comprehensive analysis of genomic data and in silico neoantigen prediction.
    Yuan Y; Chen C; Liu S; Xiong H; Huang Y; Zhang X; Zhang X; Li B
    Cell Immunol; 2022 Jul; 377():104537. PubMed ID: 35636066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial intelligence applied in neoantigen identification facilitates personalized cancer immunotherapy.
    Cai Y; Chen R; Gao S; Li W; Liu Y; Su G; Song M; Jiang M; Jiang C; Zhang X
    Front Oncol; 2022; 12():1054231. PubMed ID: 36698417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neodb: a comprehensive neoantigen database and discovery platform for cancer immunotherapy.
    Wu T; Chen J; Diao K; Wang G; Wang J; Yao H; Liu XS
    Database (Oxford); 2023 Jun; 2023():. PubMed ID: 37311149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatobiliary Tumor Organoids Reveal HLA Class I Neoantigen Landscape and Antitumoral Activity of Neoantigen Peptide Enhanced with Immune Checkpoint Inhibitors.
    Wang W; Yuan T; Ma L; Zhu Y; Bao J; Zhao X; Zhao Y; Zong Y; Zhang Y; Yang S; Qiu X; Shen S; Wu R; Wu T; Wang H; Gao D; Wang P; Chen L
    Adv Sci (Weinh); 2022 Aug; 9(22):e2105810. PubMed ID: 35665491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling of hepatocellular carcinoma neoantigens reveals immune microenvironment and clonal evolution related patterns.
    Li Z; Chen G; Cai Z; Dong X; He L; Qiu L; Zeng Y; Liu X; Liu J
    Chin J Cancer Res; 2021 Jun; 33(3):364-378. PubMed ID: 34321833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machine learning methods and harmonized datasets improve immunogenic neoantigen prediction.
    Müller M; Huber F; Arnaud M; Kraemer AI; Altimiras ER; Michaux J; Taillandier-Coindard M; Chiffelle J; Murgues B; Gehret T; Auger A; Stevenson BJ; Coukos G; Harari A; Bassani-Sternberg M
    Immunity; 2023 Nov; 56(11):2650-2663.e6. PubMed ID: 37816353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy.
    Bai P; Li Y; Zhou Q; Xia J; Wei PC; Deng H; Wu M; Chan SK; Kappler JW; Zhou Y; Tran E; Marrack P; Yin L
    Oncoimmunology; 2021 Jan; 10(1):1868130. PubMed ID: 33537173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematically Characterizing A-to-I RNA Editing Neoantigens in Cancer.
    Zhou C; Wei Z; Zhang L; Yang Z; Liu Q
    Front Oncol; 2020; 10():593989. PubMed ID: 33363023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Trends in Neoantigen-Based Cancer Vaccines.
    Ho SY; Chang CM; Liao HN; Chou WH; Guo CL; Yen Y; Nakamura Y; Chang WC
    Pharmaceuticals (Basel); 2023 Mar; 16(3):. PubMed ID: 36986491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.